Acelyrin stockholders approve merger agreement with Alumis

ACELYRIN (SLRN) announced that at the Company’s special meeting of stockholders held earlier, its stockholders voted to approve the adoption of the Company’s merger agreement with Alumis (ALMS). As previously announced, under the terms of the amended merger agreement, ACELYRIN stockholders will receive 0.4814 shares of Alumis common stock for each share of ACELYRIN common stock owned at the closing of the transaction. The final voting results of the ACELYRIN special meeting will be reported in a Form 8-K filed by ACELYRIN with the U.S. Securities and Exchange Commission. ACELYRIN expects to complete the transaction in the second quarter of 2025.